Prevalence of iron deficiency in patients admitted to a geriatric unit: a multicenter cross-sectional study.
Journal Information
Full Title: BMC Geriatr
Abbreviation: BMC Geriatr
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethics approval and consent to participateThe study conformed to the principles of the Declaration of Helsinki and Good Clinical Practice Guidelines. It was approved by a national independent Ethics Committee (“Comité de Protection des Personnes Ile de France III”) and written informed consent was obtained from all subjects participating in the trial. Consent for publicationNot applicable. Competing interestsB. Fougère: consultancies, honoraria, advisory board, speakers: AstraZeneca, Bayer, Biogen, Biophitys, BMS, Boehringer-Ingelheim, CSL Vifor, GSK, MSD, Nestlé, Novartis, Pfizer.F. Puisieux: consultancies, honoraria, advisory board, speakers’ fees: Bayer, BMS, Boehringer-Ingelheim, CSL Vifor, GSK, MSD, Sanofi, Novartis, Pfizer.P. Chevalet: speaker’s fees for Vifor.C. Annweiler: no conflict of interest.E. Michel: no conflict of interest.L. Joly: no conflict of interest.F. Blanc: no conflict of interest.A. El Azouzi: no conflict of interest.V. Desré-Follet: employee of CSL Vifor, France.P. Cacoub: consultancies, honoraria, advisory board, speakers’ fees: Alnylam, Innotech, Mylan, Pfizer, Servier, and Vifor. Competing interests B. Fougère: consultancies, honoraria, advisory board, speakers: AstraZeneca, Bayer, Biogen, Biophitys, BMS, Boehringer-Ingelheim, CSL Vifor, GSK, MSD, Nestlé, Novartis, Pfizer. F. Puisieux: consultancies, honoraria, advisory board, speakers’ fees: Bayer, BMS, Boehringer-Ingelheim, CSL Vifor, GSK, MSD, Sanofi, Novartis, Pfizer. P. Chevalet: speaker’s fees for Vifor. C. Annweiler: no conflict of interest. E. Michel: no conflict of interest. L. Joly: no conflict of interest. F. Blanc: no conflict of interest. A. El Azouzi: no conflict of interest. V. Desré-Follet: employee of CSL Vifor, France. P. Cacoub: consultancies, honoraria, advisory board, speakers’ fees: Alnylam, Innotech, Mylan, Pfizer, Servier, and Vifor."
"Funding The CARENFER PA study was funded by CSL VIFOR."
"Trial registration NCT05514951."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025